Neuroprogression: What it is and why you should know about it

by Shivani Kapadia, PharmD, Medical Director of Global Medical Affairs, Neuropsychiatry, Otsuka Pharmaceutical Development & Commercialization, Inc (OPDC); and Sara Asif Spencer, PharmD, MS, BCGP, Medical Sciences Liaison, Neuropsychiatry, OPDC

This post was sponsored and developed by Otsuka Pharmaceutical Development & Commercialization, Inc.

Physical, behavioral, and emotional changes may indicate an underlying mental health condition.4 Examples of signs and symptoms that may indicate a mental health condition include changes in eating and sleeping habits, irritability, and uncaused physical ailments.4 As with a physical health condition, a mental health condition can start out mild and worsen over time; Therefore, it is very important not to ignore these signs and symptoms.4.5

2 Delays in addressing the symptoms of a mental health condition can lead to neuroprogression.

Neuroprogression is related to a series of biological processes that contribute to the gradual worsening, relapse and recurrence of mental health conditions.6 Neuroprogression has interconnected mechanisms, influenced by physiological, neurochemical, immunological and genetic factors.6 The result is structural and functional changes in multiple systems, specifically the nervous, immune, and metabolic systems.6

3 Stress and inflammation play a role in neuroprogression.

Stress is associated with poorer physical and mental health outcomes and can exacerbate underlying or existing conditions.12 Mental health conditions are correlated with both physical and psychological stress, leading to systemic inflammation, including neuroinflammation.6.13 Prolonged inflammation can lead to structural and chemical changes in the brain associated with neuroprogression. These changes could be irreversible if untreated and may lead to worse clinical outcomes.6

4 Early detection and timely intervention can limit or stop neuroprogression.

Longer and increased episodes of mental health conditions can accelerate neuroprogression and lead to further cognitive and physical decline.1,2,7,14,15 The sooner an individual recognizes the symptoms of a potential mental health condition and seeks help, the sooner they can slow neuroprogression.16 For many mental health conditions, early intervention can lead to a greater chance of better outcomes.17 Timely intervention can help reduce the burden of disease and healthcare costs and improve the quality of life for both those with the mental health condition and their loved ones.17

5 Screening is key to early detection and early intervention

Screening is a quick way to detect symptoms of mental illness.18,19 Mental health screenings are recommended for everyone ages 8 and older and can lead to early intervention.20-23 Primary care doctors and mental health professionals can perform screenings.18 There are also free, confidential, and scientifically validated online mental health screening tools that can help you determine if you are experiencing symptoms of a mental health condition.19

6 One size does not fit all: Every mental health journey is unique!

Even with similar symptoms and the same diagnosis, each individual has a different mental health journey.24 Finding the right therapy can take time; The sooner a patient seeks therapy, the sooner they can potentially benefit from treatment.7.25 Remember that in many cases, without proper treatment, neuroprogression can go uncontrolled, worsening symptoms and making recovery more difficult.6

More information | Now that you know about neuroprogression and its impact on mental health conditions, here are some resources and options for you to learn more.

Don't ignore what your body tells you. Learn more about the warning signs and early symptoms of mental health conditions...| Click here to watch the video

Hear from a real patient about their mental health journey | Click here to watch the interview on PsychU

Finding the right support can help you manage the stress in your life | Click here to find support groups in your area

Learn more about the importance of early intervention | Click here to read the article.

Take a load off your shoulders: get a screening test | Click here to access MHA screening tools

Learn more about the recovery journey | Click here to read more about recovery

Shivani Kapadia, PharmD, is medical director of global medical affairs, neuropsychiatry, at Otsuka Pharmaceutical Development & Commercialization, Inc (OPDC). She received her doctor of pharmacy degree from St. John’s University in Queens, New York.

Sara Asif Spencer, PharmD, MS, BCGP, is a medical science liaison, neuropsychiatry, at OPDC. She received her doctor of pharmacy degree from Albany College of Pharmacy in Albany, New York.

The views and opinions expressed in this blog are solely those of the author and external content does not necessarily reflect the views of Mental Health America.

References

  1. Berk M. Neuroprogression: pathways to progressive brain changes in bipolar disorder. Int J Neuropsychopharmacol. 2009;12(4):441-445. doi:10.1017/S1461145708009498
  2. Lieberman JA, Perkins D, Belger A, et al. The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. [published correction appears in Biol Psychiatry. 2002;51(4):346]. Biological psychiatry. 2001;50(11):884-897. doi:10.1016/s0006-3223(01)01303-8
  3. Kanter JW, Busch AM, Weeks CE, Landes SJ. The nature of clinical depression: Symptoms, syndromes, and behavioral analysis. anal behavior. 2008;31(1):1-21. doi:10.1007/BF03392158
  4. American Psychiatric Association. Warning signs of mental illness. Accessed July 15, 2024. https://www.psychiatry.org/patients-families/warning-signs-of-mental-illness
  5. American mental health. Is mental illness physical or mental? Accessed July 19, 2024. https://screening.mhanational.org/content/mental-illness-physical-or-mental/
  6. Halaris A, Leonard BE. Unravel the complex interplay of immunometabolic systems that contribute to the neuroprogression of psychiatric disorders. Neurol Psychiatry Brain Res. 2019;32:111-121. doi:10.1016/j.npbr.2019.05.005
  7. Post RM, Fleming J, Kapczinski F. Neurobiological correlates of disease progression in recurrent affective disorders. J Psychiatrist Res. 2012;46(5):561-573. doi:10.1016/j.jpsychires.2012.02.004
  8. Fond G, Lançon C, Korchia T, Auquier P, Boyer L. The role of inflammation in the treatment of schizophrenia. Frontal psychiatry. 2020;11:160. doi:10.3389/fpsyt.2020.00160
  9. Lee DH, Lee JY, Hong DY, et al. Neuroinflammation in post-traumatic stress disorder. Biomedicines. 2022;10(5):953. doi:10.3390/biomedicines10050953
  10. Hassamal S. Chronic stress, neuroinflammation and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories. Frontal psychiatry. 2023;14:1130989. doi:10.3389/fpsyt.2023.1130989
  11. Calcia MA, Bonsall DR, Bloomfield PS, Selvaraj S, Barichello T, Howes OD. Stress and neuroinflammation: a systematic review of the effects of stress on microglia and implications for mental illness. Psychopharmacology (Berl). 2016;233(9)1637-1650. doi:/10.1007/s00213-016-4218-9
  12. Schneiderman N, Ironson G, Siegel SD. Stress and health: psychological, behavioral and biological determinants. Annu Rev Clin Psychol. 2005;1:607-628. doi:10.1146/annurev.clinpsy.1.102803.144141
  13. Davis MT, Holmes SE, Pietrzak RH, Esterlis I. Neurobiology of chronic stress-related psychiatric disorders: evidence from molecular imaging studies. Chronic Stress (Thousand Oaks). 2017;1:2470547017710916. doi:10.1177/2470547017710916
  14. Wertz J, Caspi A, Ambler A, et al. Association of history of psychopathology with accelerated aging in midlife. [published correction appears in JAMA Psychiatry. 2021;78(5):569. doi:10.1001/jamapsychiatry.2021.0268]. JAMA Psychiatry. 2021;78(5):530-539. doi:10.1001/jamapsychiatry.2020.4626
  15. Ruiz NAL, Del Ángel DS, Olguín HJ, Silva ML. Neuroprogression: the hidden mechanism of depression. Neuropsychiatrist treatment. 2018;14:2837-2845. doi:10.2147/NDT.S177973
  16. Correll CU, Galling B, Pawar A, et al. Comparison of early intervention services versus treatment as usual for early phase psychosis: a systematic review, meta-analysis and meta-regression. JAMA Psychiatry. 2018;75(6):555-565. doi:10.1001/jamapsychiatry.2018.0623
  17. Singh V, Kumar A, Gupta S. Prevention and promotion of mental health: a narrative review. Frontal psychiatry. 2022;13:898009. doi:10.3389/fpsyt.2022.898009
  18. American Academy of Family Physicians. Mental and behavioral health care services provided by family physicians (position paper). Accessed July 17, 2024. https://www.aafp.org/about/policies/all/mental-health-services.html
  19. American mental health. About MHA screening. Accessed July 17, 2024. https://mhanational.org/cri/screening
  20. US Preventive Services Task Force Screening for anxiety in children and adolescents: US Preventive Services Task Force recommendation statement. JAMA. 2022;328(14):1438-1444. doi:10.1001/jama.2022.16936
  21. US Preventive Services Task Force Screening for depression and suicide risk in children and adolescents: US Preventive Services Task Force recommendation statement. JAMA. 2022;328(15):1534-1542. doi:10.1001/jama.2022.16946
  22. US Preventive Services Task Force Screening for anxiety disorders in adults: US Preventive Services Task Force recommendation statement. JAMA. 2023;329(24):2163-2170. doi:10.1001/jama.2023.9301
  23. US Preventive Services Task Force Screening for depression and suicide risk in adults: US Preventive Services Task Force recommendation statement. JAMA. 2023;329(23):2057-2067. doi:10.1001/jama.2023.9297
  24. American mental health. Mental health treatments. Accessed July 17, 2024. https://mhanational.org/mental-health-treatments
  25. American mental health. Find the right clinical mental health care for you. Accessed July 17, 2024. https://www.mhanational.org/finding-right-mental-health-care-you
We will be happy to hear your thoughts

Leave a reply

Tools4BLS
Logo
Register New Account
Compare items
  • Total (0)
Compare
0
Shopping cart